Hong Kong Pharma Stock Market Value
| HKPD Stock | 0.83 0 0.12% |
| Symbol | Hong |
Is Air Freight & Logistics space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hong Kong. If investors know Hong will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hong Kong listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.302 | Revenue Per Share | Quarterly Revenue Growth (0.05) | Return On Assets | Return On Equity |
The market value of Hong Kong Pharma is measured differently than its book value, which is the value of Hong that is recorded on the company's balance sheet. Investors also form their own opinion of Hong Kong's value that differs from its market value or its book value, called intrinsic value, which is Hong Kong's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hong Kong's market value can be influenced by many factors that don't directly affect Hong Kong's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hong Kong's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hong Kong is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hong Kong's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Hong Kong 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hong Kong's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hong Kong.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in Hong Kong on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Hong Kong Pharma or generate 0.0% return on investment in Hong Kong over 90 days. Hong Kong is related to or competes with Lakeside Holding, PS International, Freightos Limited, Universal Security, New Century, Jayud Global, and Ten League. Hong Kong is entity of United States. It is traded as Stock on NASDAQ exchange. More
Hong Kong Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hong Kong's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hong Kong Pharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 65.54 | |||
| Value At Risk | (8.08) | |||
| Potential Upside | 6.67 |
Hong Kong Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hong Kong's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hong Kong's standard deviation. In reality, there are many statistical measures that can use Hong Kong historical prices to predict the future Hong Kong's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (1.03) | |||
| Treynor Ratio | (0.30) |
Hong Kong January 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.29) | |||
| Mean Deviation | 3.78 | |||
| Coefficient Of Variation | (2,454) | |||
| Standard Deviation | 7.57 | |||
| Variance | 57.37 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (1.03) | |||
| Treynor Ratio | (0.30) | |||
| Maximum Drawdown | 65.54 | |||
| Value At Risk | (8.08) | |||
| Potential Upside | 6.67 | |||
| Skewness | 3.59 | |||
| Kurtosis | 24.52 |
Hong Kong Pharma Backtested Returns
Hong Kong Pharma holds Efficiency (Sharpe) Ratio of -0.19, which attests that the entity had a -0.19 % return per unit of risk over the last 3 months. Hong Kong Pharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Hong Kong's Risk Adjusted Performance of (0.02), standard deviation of 7.57, and Market Risk Adjusted Performance of (0.29) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.07, which attests to a somewhat significant risk relative to the market. Hong Kong returns are very sensitive to returns on the market. As the market goes up or down, Hong Kong is expected to follow. At this point, Hong Kong Pharma has a negative expected return of -0.8%. Please make sure to check out Hong Kong's value at risk and the relationship between the accumulation distribution and relative strength index , to decide if Hong Kong Pharma performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.48 |
Modest reverse predictability
Hong Kong Pharma has modest reverse predictability. Overlapping area represents the amount of predictability between Hong Kong time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hong Kong Pharma price movement. The serial correlation of -0.48 indicates that about 48.0% of current Hong Kong price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.48 | |
| Spearman Rank Test | -0.74 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Hong Kong Pharma is a strong investment it is important to analyze Hong Kong's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Hong Kong's future performance. For an informed investment choice regarding Hong Stock, refer to the following important reports:Check out Hong Kong Correlation, Hong Kong Volatility and Hong Kong Alpha and Beta module to complement your research on Hong Kong. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Hong Kong technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.